Calidi Biotherapeutics Provides Required NYSE American Disclosure
May 22, 2026 18:00 ET | Source: Calidi Biotherapeutics, Inc SAN DIEGO,…
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis onAugust 5, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi”…
